NCT05081245Phase 2Completed

ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

Study sponsor: MapLight Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-03-10Actual
Enrollment · participants168Actual
Source updated2026-05-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 150 participants (planned). After: 168 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2026. After: 10 Mar 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview